Hepavil 140 Tablet is a combination pharmaceutical formulation containing L-Ornithine L-Aspartate (250 mg) and Silymarin (70 mg), designed to support liver function and promote hepatic health. L-Ornithine L-Aspartate is an amino acid compound that plays a crucial role in ammonia detoxification by enhancing the urea cycle, thereby reducing elevated blood ammonia levels commonly associated with hepatic encephalopathy and liver dysfunction. Silymarin, a flavonoid complex extracted from the milk thistle plant, exhibits potent antioxidant, anti-inflammatory, and hepatoprotective properties. It stabilizes hepatocyte membranes, promotes liver cell regeneration, and inhibits toxin-induced liver damage. The synergistic action of these two active ingredients makes Hepavil 140 effective in managing chronic liver diseases such as cirrhosis, hepatitis, and fatty liver disease. It is also indicated for the treatment of hepatic encephalopathy and for improving overall liver function in patients with compromised hepatic metabolism. Hepavil 140 is generally well-tolerated, but it should be used under medical supervision, particularly in patients with severe liver impairment or those on concomitant medications. Regular monitoring of liver function tests is recommended to assess therapeutic efficacy and safety during treatment.